✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Sanofi India Ltd

Common Name
Sanofi India
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
1,225
Ticker
SANOFI
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Sanofi India Limited, a prominent pharmaceutical company, plays a significant role in the healthcare sector by manufacturing and distributing a wide range of pharmaceutical products. As a subsidiary o...

Sanofi India's GHG Emissions Data Preview

In 2024, Sanofi India completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, Sanofi India has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)202420232022
2021 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
0000000
Total Scope 2
Unspecified Calculation Method
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
0000000
Total Scope 3
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
a
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
a
Copy/Paste is a PRO feature.
0000000
Limited Data Preview
You are viewing a limited preview of Sanofi India’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2023, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=SANOFI&reporting_period=2024"

Verified Sources Behind Sanofi India’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sanofi India’s data sources below and access millions more through our Disclosure Search.

a. Sanofi India's Annual Report 2024

Insights into Sanofi India's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Sanofi India amounted to 8,331.68 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Sanofi India decreased by 7.05%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Sanofi India's Scope 1 Emissions Over Time

202320240150300450600tCO2e+5%
  • Total Scope 1
  • Year-over-Year Change

What are Sanofi India's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Sanofi India were 509.68 metric tons of CO₂ equivalent (tCO₂e).a

Compared to the previous year (2023), Sanofi India's Scope 1 emissions increased by 4.74%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a

What are Sanofi India's Scope 2 emissions?

In 2024, Sanofi India reported Scope 2 greenhouse gas (GHG) emissions of 7,822 tCO₂e without specifying the calculation method.a

Has Sanofi India reduced its Scope 2 emissions over time?

Compared to the previous year (2023), Sanofi India's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Sanofi India's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does Sanofi India use for Scope 2 reporting?

In 2024, Sanofi India reported its Scope 2 emissions using an unspecified methodology.a

Sanofi India's Scope 2 Emissions Over Time

2023202402.5 k5 k7.5 k10 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Sanofi India's Value Chain Emissions

In 2024, Sanofi India reported 20,591 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2024 disclosure of Sanofi India includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a

Sanofi India's Scope 3 Emissions Over Time

2023202406.5 k13 k19.5 k26 ktCO2e-20%
  • Total Scope 3
  • Year-over-Year Change

What are Sanofi India's Scope 3 emissions?

In 2024, Sanofi India reported total Scope 3 emissions of 20,591 metric tons of CO₂ equivalent (tCO₂e).a

Compared to the previous year (2023), Sanofi India's Scope 3 emissions decreased by 19.98%, highlighting the company's efforts to lower indirect emissions from its value chain.a

Insights into Sanofi India’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Sanofi India reported Scope 1 greenhouse gas (GHG) emissions of 509.68 tCO₂e and total revenues of USD 232 millions. This translates into an emissions intensity of 2.2 tCO₂e per millions USD.a

Sanofi India's Scope 1 Emissions Intensity Compared to Peers

1002,00020,000200,0002,000,000Scope 1 Emissions (tCO2e)502001,0002,00010,000Revenues (Millions of USD)NBOESNNNeuland LaboratoriesYear: 2025Scope 1: 27,761 tCO2eRevenue: $M 168Scope 1 Intensity: 165.36 tCO2e/$MBBBlue Jet HealthcareYear: 2025Scope 1: 23,877 tCO2eRevenue: $M 120Scope 1 Intensity: 198.82 tCO2e/$MGlaxoSmithKline PharmaceuticalsYear: 2025Scope 1: 1,003 tCO2eRevenue: $M 436Scope 1 Intensity: 2.30 tCO2e/$MKIMS HospitalsYear: 2025Scope 1: 1,057 tCO2eRevenue: $M 355Scope 1 Intensity: 2.98 tCO2e/$MAarti PharmalabsYear: 2024Scope 1: 88,101 tCO2eRevenue: $M 218Scope 1 Intensity: 404.68 tCO2e/$MCiplaYear: 2025Scope 1: 38,283 tCO2eRevenue: $M 3,177Scope 1 Intensity: 12.05 tCO2e/$MSyngene InternationalYear: 2025Scope 1: 6,637 tCO2eRevenue: $M 411Scope 1 Intensity: 16.14 tCO2e/$MJB PharmaYear: 2025Scope 1: 5,652 tCO2eRevenue: $M 452Scope 1 Intensity: 12.50 tCO2e/$MNatco PharmaYear: 2025Scope 1: 28,495 tCO2eRevenue: $M 518Scope 1 Intensity: 54.96 tCO2e/$MGlenmark PharmaceuticalsYear: 2025Scope 1: 34,547 tCO2eRevenue: $M 1,539Scope 1 Intensity: 22.45 tCO2e/$MTorrent PharmaceuticalsYear: 2025Scope 1: 8,937 tCO2eRevenue: $M 1,325Scope 1 Intensity: 6.75 tCO2e/$MStrides Pharma ScienceYear: 2023Scope 1: 6,168 tCO2eRevenue: $M 439Scope 1 Intensity: 14.04 tCO2e/$MCohance LifesciencesYear: 2025Scope 1: 31,818 tCO2eRevenue: $M 140Scope 1 Intensity: 227.00 tCO2e/$MOOOrchid PharmaYear: 2025Scope 1: 74,800 tCO2eRevenue: $M 108Scope 1 Intensity: 693.22 tCO2e/$MAlkem LaboratoriesYear: 2025Scope 1: 33,018 tCO2eRevenue: $M 1,499Scope 1 Intensity: 22.03 tCO2e/$MGland PharmaYear: 2025Scope 1: 13,920 tCO2eRevenue: $M 654Scope 1 Intensity: 21.30 tCO2e/$MPoly MedicureYear: 2025Scope 1: 3,338 tCO2eRevenue: $M 195Scope 1 Intensity: 17.08 tCO2e/$MLupinYear: 2025Scope 1: 82,174 tCO2eRevenue: $M 2,597Scope 1 Intensity: 31.64 tCO2e/$MFortis HealthcareYear: 2025Scope 1: 4,600 tCO2eRevenue: $M 904Scope 1 Intensity: 5.09 tCO2e/$MSun Pharmaceutical IndustriesYear: 2025Scope 1: 156,242 tCO2eRevenue: $M 6,091Scope 1 Intensity: 25.65 tCO2e/$MApollo Hospitals EnterpriseYear: 2024Scope 1: 731,919 tCO2eRevenue: $M 2,262Scope 1 Intensity: 323.59 tCO2e/$MEEEris LifesciencesYear: 2025Scope 1: 1,083 tCO2eRevenue: $M 337Scope 1 Intensity: 3.21 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MIPCA LaboratoriesYear: 2025Scope 1: 169,992 tCO2eRevenue: $M 1,036Scope 1 Intensity: 164.03 tCO2e/$MSSSanofi IndiaYear: 2024Scope 1: 510 tCO2eRevenue: $M 232Scope 1 Intensity: 2.20 tCO2e/$M

How does Sanofi India's GHG emissions intensity compare to its peers?

In 2024, Sanofi India reported a Scope 1 emissions intensity of 2.2 tCO₂e per millions USD. Compared to the peer group median of 22.24, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Sanofi India rank on GHG emissions intensity within its industry?

In 2024, Sanofi India ranked 1 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

This places Sanofi India among the top performers, with one of the lowest emissions intensities relative to peers.a

Insights into Sanofi India's Total Carbon Footprint

In 2024, Sanofi India reported a total carbon footprint of 28,922.68 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 16.64% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.a

The largest contributor to Sanofi India's total carbon footprint was Scope 3 emissions, accounting for 71.19% of the company's total carbon footprint, followed by Scope 2 emissions at 27.04%.a

Want Full Access to Sanofi India's GHG Emissions Dataset?
Start 30-Day Free Trial